Free Trial

10 Best Small Cap Stocks to Buy Now - 9 of 10

 
 

GeoVax Labs (NASDAQ:GOVX)

Consensus Rating
Buy
Rating Score
3.4
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$12.67 (530.2% Upside)

About GeoVax Labs

GeoVax Labs logoGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/19/2024Noble FinancialBoost Price TargetOutperform ➝ Outperform$6.00 ➝ $10.00
8/12/2024HC WainwrightReiterated RatingBuy ➝ Buy$8.00 ➝ $8.00
7/23/2024EF Hutton Acquisition Co. IUpgradeStrong-Buy
7/16/2024Roth CapitalUpgradeStrong-Buy
7/16/2024Roth MkmInitiated CoverageBuy$20.00
7/2/2024HC WainwrightReiterated RatingBuy ➝ Buy$8.00 ➝ $8.00
6/18/2024HC WainwrightBoost Price TargetBuy ➝ Buy$8.00 ➝ $120.00
11/13/2023HC WainwrightReiterated RatingBuy ➝ Buy$120.00
10/9/2023HC WainwrightReiterated RatingBuy ➝ Buy$120.00
8/31/2023HC WainwrightReiterated RatingBuy ➝ Buy$120.00
 

What The Recent Selloffs Really Mean (Ad)

There is nothing the Federal Reserve can do on September 18 to stop what's coming next for U.S. stocks.

Click here to view my new presentation now.